Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Anal cancer, Bile duct cancer, Biliary tree cancers, Bladder cancer, Bone cancer, Bowel (colorectal) cancer, Breast cancer, Cancer spread to the bone, Cancer spread to the brain, Cancer spread to the liver, Cancer spread to the lung, Cervical cancer, Colon cancer, Gallbladder cancer, Head and neck cancers, Laryngeal cancer, Lung cancer, Mouth and oropharyngeal cancer, Nasal and paranasal sinus cancer , Nasopharyngeal cancer, Non melanoma skin cancer, Oesophageal cancer, Pancreatic cancer, Penile cancer, Pharyngeal cancer, Prostate cancer, Rectal cancer, Salivary gland cancer, Sarcoma, Secondary cancers, Skin cancer, Small bowel cancer, Soft tissue sarcoma, Squamous cell skin cancer, Stomach cancer, Vaginal cancer, Vulval cancer, Womb (uterine or endometrial) cancer
Closed
Other
This study is open to people whose cancer has spread and who are due treatment with a biological therapy by itself, or with chemotherapy.
Recruitment start: 2 December 2014
Recruitment end: 30 June 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Harpreet Wasan
Experimental Cancer Medicine Centre (ECMC)
Imperial College London
StratiGrad
Last reviewed: 22 April 2024
CRUK internal database number: 14103